Ceramide 1-Phosphate Is Required for the Translocation of Group IVA Cytosolic Phospholipase A2 and Prostaglandin Synthesis*

Little is known about the regulation of eicosanoid synthesis proximal to the activation of cytosolic phospholipase A2α (cPLA2α), the initial rate-limiting step. The current view is that cPLA2α associates with intracellular/phosphatidylcholine-rich membranes strictly via hydrophobic interactions in response to an increase of intracellular calcium. In opposition to this accepted mechanism of two decades, ceramide 1-phosphate (C1P) has been shown to increase the membrane association of cPLA2α in vitro via a novel site in the cationic β-groove of the C2 domain (Stahelin, R. V., Subramanian, P., Vora, M., Cho, W., and Chalfant, C. E. (2007) J. Biol. Chem. 282, 20467–204741). In this study we demonstrate that C1P is a proximal and required bioactive lipid for the translocation of cPLA2α to intracellular membranes in response to inflammatory agonists (e.g. calcium ionophore and ATP). Last, the absolute requirement of the C1P/cPLA2α interaction was demonstrated for the production of eicosanoids using murine embryonic fibroblasts (cPLA2α−/−) coupled to “rescue” studies. Therefore, this study provides a paradigm shift in how cPLA2α is activated during inflammation.

[1]  James G. Bollinger,et al.  Role of Phosphorylation and Basic Residues in the Catalytic Domain of Cytosolic Phospholipase A2α in Regulating Interfacial Kinetics and Binding and Cellular Function* , 2009, Journal of Biological Chemistry.

[2]  B. Kinzel,et al.  Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice. , 2008, Biochemical and biophysical research communications.

[3]  A. Rubartelli,et al.  ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way , 2008, Proceedings of the National Academy of Sciences.

[4]  C. Leslie,et al.  cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells Published, JLR Papers in Press, January 9, 2008. , 2008, Journal of Lipid Research.

[5]  T. Ullrich,et al.  Regulation and Traffic of Ceramide 1-Phosphate Produced by Ceramide Kinase , 2008, Journal of Biological Chemistry.

[6]  C. Chalfant,et al.  Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms Published, JLR Papers in Press, September 21, 2007. , 2007, Journal of Lipid Research.

[7]  B. Sperlágh,et al.  P2X3 Receptor Involvement in Pain States , 2007, Molecular Neurobiology.

[8]  C. Chalfant,et al.  Ceramide-1-phosphate Binds Group IVA Cytosolic Phospholipase a2 via a Novel Site in the C2 Domain* , 2007, Journal of Biological Chemistry.

[9]  A. Merrill,et al.  Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesiss⃞ Published, JLR Papers in Press, March 27, 2007. , 2007, Journal of Lipid Research.

[10]  R. Malaviya,et al.  Targeting cytosolic phospholipase A2 by arachidonyl trifluoromethyl ketone prevents chronic inflammation in mice. , 2006, European journal of pharmacology.

[11]  W. Thomas,et al.  Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells , 2006, Steroids.

[12]  J. Balsinde,et al.  Phosphatidylinositol 4,5-bisphosphate anchors cytosolic group IVA phospholipase A2 to perinuclear membranes and decreases its calcium requirement for translocation in live cells. , 2005, Molecular biology of the cell.

[13]  A. Merrill,et al.  Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. , 2005, Methods.

[14]  A. Bielawska,et al.  Ceramide 1-Phosphate Acts as a Positive Allosteric Activator of Group IVA Cytosolic Phospholipase A2α and Enhances the Interaction of the Enzyme with Phosphatidylcholine* , 2005, Journal of Biological Chemistry.

[15]  F. Di Virgilio,et al.  Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapy. , 2005, Current drug targets. Cardiovascular & haematological disorders.

[16]  M. Wick,et al.  Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice. , 2004, Carcinogenesis.

[17]  C. Leslie,et al.  Ceramide 1-Phosphate Is a Direct Activator of Cytosolic Phospholipase A2* , 2004, Journal of Biological Chemistry.

[18]  A. Bielawska,et al.  Ceramide Kinase Mediates Cytokine- and Calcium Ionophore-induced Arachidonic Acid Release* , 2003, Journal of Biological Chemistry.

[19]  Lian-san Zhao,et al.  [Isolation and culture of mouse embryonic fibroblast]. , 2003, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[20]  Ximena Opitz-Araya,et al.  Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization , 2002, Science.

[21]  C. Leslie,et al.  Intracellular Calcium Signals Regulating Cytosolic Phospholipase A2 Translocation to Internal Membranes* 210 , 2001, The Journal of Biological Chemistry.

[22]  F. Traganos,et al.  Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs: implications for colon cancer chemoprevention. , 2001, Cancer research.

[23]  B. Johansen,et al.  Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  P. Cohen,et al.  Serine 727 Phosphorylation and Activation of Cytosolic Phospholipase A2 by MNK1-related Protein Kinases* , 2000, The Journal of Biological Chemistry.

[25]  J. Balsinde,et al.  Cellular Regulation of Cytosolic Group IV Phospholipase A2 by Phosphatidylinositol Bisphosphate Levels1 , 2000, The Journal of Immunology.

[26]  E. Fosslien Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia , 2000, Critical reviews in clinical laboratory sciences.

[27]  B. Samuelsson,et al.  Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[29]  S. Chatterjee Sphingolipids in atherosclerosis and vascular biology. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[30]  Y. Yatabe,et al.  Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.

[31]  C. Leslie Properties and Regulation of Cytosolic Phospholipase A2 * , 1997, The Journal of Biological Chemistry.

[32]  R. Kramer,et al.  Structure, function and regulation of Ca2+‐sensitive cytosolic phospholipase A2 (cPLA2) , 1997, FEBS letters.

[33]  R. White,et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. D. Clark,et al.  Cytosolic phospholipase A2. , 1995, Journal of lipid mediators and cell signalling.

[35]  H. Jacob,et al.  Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers. , 1995, Genomics.

[36]  R. Kriz,et al.  Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. , 1994, The Journal of biological chemistry.

[37]  E. Dennis,et al.  Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2. , 1993, Biochimica et biophysica acta.

[38]  J. R. Sportsman,et al.  Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. , 1991, The Journal of biological chemistry.

[39]  J. D. Clark,et al.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP , 1991, Cell.

[40]  C. Leslie,et al.  A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. , 1990, The Journal of biological chemistry.

[41]  M. Boyd,et al.  Evidence for prostanoid biosynthesis as a biochemical feature of certain subclasses of non-small cell carcinomas of the lung as determined in established cell lines derived from human lung tumors. , 1989, Cancer research.

[42]  M. Boyd,et al.  Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. , 1988, Cancer research.

[43]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[44]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[45]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[46]  F. Goñi,et al.  Effects of ceramide and other simple sphingolipids on membrane lateral structure. , 2009, Biochimica et biophysica acta.

[47]  A. Merrill,et al.  Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics. , 2007, Methods in enzymology.

[48]  A. Bielawska,et al.  Quantitative determination of ceramide using diglyceride kinase. , 2000, Methods in enzymology.